NEW YORK, NY, (NewMediaWire) - January 11, 2018 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that the Company has completed the purchase of its second tranche of the crypto currency called: Groestlcoin (code: GRS).
The Company had previously disclosed, via press release on December 27, 2017, that it decided to diversify $25,000 of its Net Cash Position into Groestlcoin (“GRS”) and Gain Exposure to the Crypto Currency Sector.
On January 11, 2018, the Company purchased $5,500 of Groestlcoin for 4,007.364 GRS units and now owns a total of 3,805.835 + 4,007.364 = 7,813.199 GRS units. The Company expects to complete the balance of this $25,000 aggregate purchase of Groestlcoin over the next week or two (through the purchases of several different tranches).
The Company continues to utilize the crypto currency exchanges of COINBASE and Livecoin.net for these purchases of these GRS units.
ABOUT TAURIGA SCIENCES, INC.
Sciences, Inc. (OTC PINK: TAUG) is engaged in building business through
the development, distribution, and licensing of proprietary products as
well as the evaluation of potential acquisition opportunities/equity
investments. The Company is presently focused on its upcoming
contemplated launch of a Cupacu Butter based lip balm product branded
under the name: Herman. The Company believes that one of its most
important strengths is its access to and relationships with potentially
substantial distribution systems and networks. The Company intends to
capitalize on distribution opportunities and will continually update
shareholders on such developments. Please visit our corporate website
press release contains certain "forward-looking statements" as defined
by the Private Securities Litigation Reform Act of 1995 which represent
management’s beliefs and assumptions concerning future events. These
forward-looking statements are often indicated by using words such as
“may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,”
or plans, and may include statements regarding corporate objectives as
well as the attainment of certain corporate goals and milestones.
Forward-looking statements are based on present circumstances and on
management’s present beliefs with respect to events that have not
occurred, that may not occur, or that may occur with different
consequences or timing than those now assumed or anticipated. Actual
results may differ materially from those expressed in forward looking
statements due to known and unknown risks and uncertainties, such as are
not guarantees of general economic and business conditions, the ability
to successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful acquisition and
licensing transactions, fluctuations in exchange rates, and other
factors over which Tauriga has little or no control. Many of these risks
and uncertainties are discussed in greater detail in the “Risk Factors”
section of Tauriga’s Form 10-K and other filings made from time to time
with the Securities and Exchange Commission. Such forward-looking
statements are made only as of the date of this release, and Tauriga
assumes no obligation to update forward-looking statements to reflect
subsequent events or circumstances. You should not place undue reliance
on these forward-looking statements.
CONTACT INFORMATION Tauriga Sciences, Inc. 555 Madison Avenue, 5th Floor New York, NY 10022 Chief Executive Officer Mr. Seth M. Shaw Email: email@example.com cell # (917) 796 9926 www.tauriga.com